In recent years, copay cards and coupons have become wildly popular with consumers who believe they can save significant sums at the pharmacy counter. But in a twist, Pfizer (PFE) has agreed to pay $700,000 to settle charges of misleading people who actually had to spend much more than expected.

As part of its program, consumers were told they would “pay no more than” a small amount of money — from $15 to $25 — for certain medicines, but were actually required to pay more because of limits on total savings that were not prominently disclosed. In one instance, a woman had to pay $144.62, according to New York Attorney General Barbara Underwood.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy